You conveniently left out the fact that the investment is to be in staged tranches.
For all we know the initial tranche for early stage research could be as little as $1m with the balance to potentially tipped in over 15 years of development.
All I know is Starpharma have chosen to give away their IP in exchange for a minority equity stake in a new non-listed entity controlled by others, rather than demanding a cash up front licence fee.
That’s a fact.
Outmanoeuvred IMO.
- Forums
- ASX - By Stock
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
You conveniently left out the fact that the investment is to be...
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.11M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14171 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 1908 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14171 | 0.090 |
1 | 127200 | 0.087 |
1 | 6395 | 0.086 |
3 | 86000 | 0.085 |
1 | 32500 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 1908 | 1 |
0.092 | 5652 | 1 |
0.093 | 65000 | 1 |
0.095 | 40000 | 1 |
0.097 | 50000 | 1 |
Last trade - 08.50am 15/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online